Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|August 2, 2021
Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human PlasmaPavlo Gilchuk, Adrian Guthals, Stefano R Bonissone, et al.
Antibody Therapeutics|June 27, 2024
A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variantsMarisa L Yang, Tom Z Yuan, Kara Y Chan, et al.
JCI Insight|April 19, 2019
Human antibody response to Zika targets type-specific quaternary structure epitopesMatthew H Collins, Huy A Tu, Ciara Gimblet-Ochieng, et al.
Cell Host & Microbe|April 23, 2020
Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other AntibodiesPhilipp A Ilinykh, Kai Huang, Rodrigo I Santos, et al.
Nature Communications|January 21, 2021
Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escapeZhiqiang Ku, Xuping Xie, Edgar Davidson, et al.
Cell|March 27, 2021
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike proteinNaveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, et al.
Research Square|January 10, 2024
Anti-Ebola virus mAb 3A6 with unprecedented potency protects highly viremic animals from fatal outcome and physically lifts its glycoprotein target from the virion membraneErica Saphire, Zhe Li Salie, Zunlong Ke, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individualsElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
The Journal of Clinical Investigation|April 26, 2022
An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimerNaveenchandra Suryadevara, Andrea R Shiakolas, Laura A VanBlargan, et al.
Emerging Microbes & Infections|May 28, 2019
Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse modelXuefeng Niu, Lingzhai Zhao, Linbing Qu, et al.
Pageof 7